Quarterly report · Q2
2342.TEDINET S100PJSQ
Period2022-04-01 → 2022-09-30
Filed2022-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 48
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥12.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥6.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥135m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥1.6bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥204m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.5bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥157m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.5bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥55m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.9bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥982m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥55m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥976m | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥10.7bn | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥10.4bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥10.4bn | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥4.0bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥3.8bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.6bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.9bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.5bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥4.6bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.4bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.6bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.4bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥696m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥883m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥601m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥982m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥238m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥65m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥320m | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥3.26 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥4.79 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥109.52 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.56 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.52 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥109.31 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥56.4 | 2021-04-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 60.8% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 62.6% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 55.4% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 31
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥2m |
| Reconciling Itemsreconciling | revenue external | 2022-04-01 → 2022-09-30 | ¥1m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥111m |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.3bn |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥3m |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥153m |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥187,000 |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥92m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥5.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥3m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥246m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥97m |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥3.1bn |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6m |
| jpcrp040300-q2r_E05317-000Drug Discovery Support Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥1.6bn |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥3.6bn |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥3.6bn |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥261,000 |
| jpcrp040300-q2r_E05317-000Investments And Consulting Businessreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥117m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥6.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥6m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥1.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 513
| Item | Context | Value | Unit |
|---|---|---|---|
| Profit loss attributable to non controlling interests | Prior1YTDDuration | -5515000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | -367000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 981826000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 54891000 | JPY |
| Profit loss | Prior1YTDDuration | 976310000 | JPY |
| Profit loss | CurrentYTDDuration | 54523000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -10950000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 747000 | JPY |
| Foreign currency translation adjustment net of tax oci | Prior1YTDDuration | 6979000 | JPY |
| Foreign currency translation adjustment net of tax oci | CurrentYTDDuration | 11339000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -3970000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 12087000 | JPY |
| Comprehensive income | Prior1YTDDuration | 972339000 | JPY |
| Comprehensive income | CurrentYTDDuration | 66611000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 977854000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 66978000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | -5514000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | -367000 | JPY |
| Income before income taxes | Prior1YTDDuration | 1540987000 | JPY |
| Income before income taxes | CurrentYTDDuration | 156552000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 74798000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 58578000 | JPY |
| Impairment loss ope cf | Prior1YTDDuration | － | JPY |
| Impairment loss ope cf | CurrentYTDDuration | 47756000 | JPY |
| Amortization of goodwill ope cf | Prior1YTDDuration | 41180000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 29277000 | JPY |
| Loss on reduction of noncurrent assets ope cf | Prior1YTDDuration | 239451000 | JPY |
| Loss on reduction of noncurrent assets ope cf | CurrentYTDDuration | － | JPY |
| Subsidy income ope cf | Prior1YTDDuration | -239451000 | JPY |
| Subsidy income ope cf | CurrentYTDDuration | － | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -404000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 106000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | 80743000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | 30483000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -437000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -378000 | JPY |
| Surrender value of insurance ope cf | Prior1YTDDuration | － | JPY |
| Surrender value of insurance ope cf | CurrentYTDDuration | -155376000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 11070000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 13073000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -263452000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | 63966000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -425958000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -533459000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -148399000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 181969000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -160624000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -156848000 | JPY |
| Increase decrease in advances received ope cf | Prior1YTDDuration | 169081000 | JPY |
| Increase decrease in advances received ope cf | CurrentYTDDuration | -175307000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |